An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)

• Status: Completed
• Trial end date: 2014-04-01

Summary

In order to treat proliferative IgA Nephropathy(IgAN), The investigators designed an open, prospective, randomized parallel study to access the efficacy and safety of MMF compared to corticosteroid .

Patients who fulfill the inclusion criteria will be randomized in a 1:1 ratio to either the MMF group or corticosteroid group.

• Phase: N/A

Details

• Lead Sponsor: Zhi-Hong Liu, M.D.
• Treatments: Mycophenolate mofetil; Mycophenolic Acid; Prednisone